drugset / Trial / NCT06834009

A Study of Suzetrigine (SUZ) Spray-dried Dispersion (SSD) in Healthy Adult Panelists

NCT06834009 ↗

Phase 1 Completed 10 enrolled Vertex Pharmaceuticals Incorporated
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the sensory attributes (basic tastes, aroma, texture, mouthfeel) of SUZ SDD and assess the impact of the dose on the sensory attributes.

Timeline

Start
2025-03-10
Primary completion
2025-04-24
Completion
2025-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject SUZ Unknown — Oral

Indications

No indication recorded.